JPMorgan Downgrades Pfizer (PFE) to Neutral
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
BMO Capital Reiterates Market Perform on Pfizer (PFE) Following Investor Meetings
December 13, 2018 7:34 AM ESTBMO Capital analyst, Alex Arfaei, reiterated a Market Perform rating and $46.00 price target on Pfizer (NYSE: PFE) following recent investor meetings with management. Overall, management's commentary was in line with Arfaei's bullish views on most assets.
Management was very bullish about the... More



